The search for existing non-animal alternative methods for use in experiments is currently challenging because of the lack of both comprehensive structured databases and balanced keyword-based search strategies to mine unstructured textual databases. In this paper we describe 3Ranker, which is a fast, keyword-independent algorithm for finding non-animal alternative methods for use in biomedical research. The 3Ranker algorithm was created by using a machine learning approach, consisting of a Random Forest model built on a dataset of 35 million abstracts and constructed with weak supervision, followed by iterative model improvement with expert curated data. We found a satisfactory trade-off between sensitivity and specificity, with Area Under the Curve (AUC) values ranging from 0.85-0.95. Trials showed that the AI-based classifier was able to identify articles that describe potential alternatives to animal use, among the thousands of articles returned by generic PubMed queries on dermatitis and Parkinson's disease. Application of the classification models on time series data showed the earlier implementation and acceptance of Three Rs principles in the area of cosmetics and skin research, as compared to the area of neurodegenerative disease research. The 3Ranker algorithm is freely available at www.open3r.org; the future goal is to expand this framework to cover multiple research domains and to enable its broad use by researchers, policymakers, funders and ethical review boards, in order to promote the replacement of animal use in research wherever possible.

Download full-text PDF

Source
http://dx.doi.org/10.1177/02611929231210777DOI Listing

Publication Analysis

Top Keywords

non-animal alternative
12
alternative methods
12
algorithm finding
8
finding non-animal
8
3ranker algorithm
8
3ranker
4
3ranker ai-based
4
algorithm
4
ai-based algorithm
4
methods search
4

Similar Publications

A recently published report from the UK National Centre for the Replacement, Refinement, and Reduction of Animals in Research (NC3Rs) has highlighted significant opportunities for the broader inclusion of 3Rs approaches (i.e. Replacement, Reduction and Refinement of animal tests) within World Health Organization (WHO) manuals, guidelines and recommendations for vaccines and biotherapeutics.

View Article and Find Full Text PDF

The workshop titled State of the Science on Assessing Developmental Neurotoxicity Using New Approach Methods was co-organized by University of Maryland's Joint Institute for Food Safety and Applied Nutrition (JIFSAN) and the U.S. Food and Drug Administration's (FDA) Center for Food Safety and Applied Nutrition (CFSAN; now called the Human Foods Program), and was hosted by FDA in College Park, MD on November 14-15, 2023.

View Article and Find Full Text PDF

Hybrid model development through the integration of quantitative read-across (qRA) hypothesis with the QSAR framework: An alternative risk assessment of acute inhalation toxicity testing in rats.

Chemosphere

December 2024

Drug Theoretics and Cheminformatics Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, 700032, India. Electronic address:

Regulatory authorities frequently need information on a chemical's capacity to produce acute systemic toxicity in humans. Due to concerns about animal welfare, human relevance, and reproducibility, numerous international initiatives have centered on finding a substitute for using animals in acute systemic lethality testing. These substitutes include the more current in-silico and in vitro techniques.

View Article and Find Full Text PDF

The chances and opportunities in modern biology inspired devising new therapeutics are mind blowing. The promises reach from successfully treating so-far incurable diseases like cancer and certain infections, to modulating and fine tuning the immune response to prolong the lifespan by inhibiting aging. However, as underlying therapies become more and more complex and sophisticated, it becomes increasingly difficult to find ways to ensure and predict the safety of these new therapeutics.

View Article and Find Full Text PDF

Sun persuades excess ROS production in the skin, altering pro-inflammatory factors and cellular responses, thereby contributing to the progression of skin disorders and skin cancer. In this study, the non-animal, and methods have been employed to interpret the potential of bioactive mangiferin against skin inflammation and skin cancer. In the approach, auto blind docking tool CB Dock 2 was utilized to assess and compare the efficacy of mangiferin against some conventional drugs like aspirin, diclofenac, betamethasone for inflammation and with 5-fluorouracil, docetaxel, doxorubicin, imiquimod, paclitaxel, sonidegib, vincristine and vismodegib for skin cancer.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!